A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis
Condition: Dermatomyositis Interventions: Drug: GLPG3667; Drug: Placebo Sponsor: Galapagos NV Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials